The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
1996

Weight Loss and Interleukin 6 in Lung Cancer

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): HR Scott, DC McMillan, A Crilly, CS McArdle, R Milroy

Primary Institution: Stobhil NHS Trust and Royal Infirmary, Glasgow, UK

Hypothesis

Does interleukin 6 play a role in weight loss among non-small-cell lung cancer patients?

Conclusion

The study found that interleukin 6 levels were higher in lung cancer patients who experienced significant weight loss.

Supporting Evidence

  • Patients with weight loss had significantly higher levels of interleukin 6.
  • There was a strong correlation between interleukin 6 and C-reactive protein levels.
  • Weight loss in lung cancer patients is associated with an active acute phase response.

Takeaway

This study shows that when lung cancer patients lose weight, a substance called interleukin 6 in their blood goes up, which might be making them lose weight.

Methodology

Patients with and without weight loss were studied, measuring various blood parameters and interleukin 6 levels.

Limitations

The study had a small sample size and was limited to patients without infections or prior treatments.

Participant Demographics

Patients were diagnosed with non-small-cell lung cancer, with a mix of sexes and ages ranging from 51 to 83 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication